James R. Heath

James R. Heath

California Institute of Technology

H-index: 130

North America-United States

About James R. Heath

James R. Heath, With an exceptional h-index of 130 and a recent h-index of 65 (since 2020), a distinguished researcher at California Institute of Technology, specializes in the field of chemistry, oncology, biotechnology, materials science, physics.

His recent articles reflect a diverse array of research interests and contributions to the field:

Correction: Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19

CITE-seq analysis reveals human cytomegalovirus and diabetes-associated adaptive NK cell alterations in cardiovascular disease.

Abstract SY41-02: Experimental methods for high throughput discovery and validation of tumor antigens

Signaling and transcriptional dynamics underlying early adaptation to oncogenic BRAF inhibition

Integrative systems biology reveals NKG2A-biased immune responses correlate with protection in infectious disease, autoimmune disease, and cancer

Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised …

Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19

A systems pharmacology approach to discover synergistic targeted therapy combinations

James R. Heath Information

University

Position

___

Citations(all)

94933

Citations(since 2020)

21862

Cited By

80656

hIndex(all)

130

hIndex(since 2020)

65

i10Index(all)

362

i10Index(since 2020)

232

Email

University Profile Page

Google Scholar

James R. Heath Skills & Research Interests

chemistry

oncology

biotechnology

materials science

physics

Top articles of James R. Heath

CITE-seq analysis reveals human cytomegalovirus and diabetes-associated adaptive NK cell alterations in cardiovascular disease.

bioRxiv

2024

Abstract SY41-02: Experimental methods for high throughput discovery and validation of tumor antigens

Cancer Research

2024/4/5

Signaling and transcriptional dynamics underlying early adaptation to oncogenic BRAF inhibition

bioRxiv

2024

Integrative systems biology reveals NKG2A-biased immune responses correlate with protection in infectious disease, autoimmune disease, and cancer

Cell Reports

2024/3/26

A systems pharmacology approach to discover synergistic targeted therapy combinations

Cancer Research

2023/4/4

Monitoring of neoantigens and adoptively transferred personalized neoTCR T cell populations in the tumor and PBMCs of patients with solid tumors

Cancer Research

2023/4/4

Stereochemical engineering yields a multifunctional peptide macrocycle inhibitor of Akt2 by fine-tuning macrocycle-cell membrane interactions

Communications Chemistry

2023/5/18

Pairing antigen specificity of at cell with t cell receptor sequences

2023/3/9

Single chain trimer mhc class ii nucleic acids and proteins and methods of use

2023/3/9

Phosphorylated akt-specific capture agents, compositions, and methods of using and making

2023/1/19

Large libraries of single-chain trimer peptide-MHCs enable antigen-specific CD8+ T cell discovery and analysis

Communications Biology

2023/5/16

Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

The Lancet Diabetes & Endocrinology

2023/12/1

T cell receptor sequences are the dominant factor contributing to the phenotype of CD8+ T cells with specificities against immunogenic viral antigens

Cell reports

2023/11/28

See List of Professors in James R. Heath University(California Institute of Technology)